testosterone undecanoate has been researched along with cyproterone acetate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Asscheman, H; Eklund, PL; Gooren, LJ | 1 |
| Bremner, WJ; Capelli, M; Costantino, A; Flamigni, C; Meriggiola, MC; Pavani, A | 1 |
| Bertaccini, A; Bremner, WJ; Cerpolini, S; Costantino, A; Huebler, D; Kirsch, B; Meriggiola, MC; Morselli-Labate, AM; Pelusi, C; Pelusi, G | 1 |
| Bhande, SS; Garg, S; Lohiya, NK; Manivannan, B; Panneerdoss, S | 1 |
| Fisher, A; Fisher, AD; Haraldsen, I; Kaufman, JM; Schreiner, T; T'Sjoen, G; Toye, K; Van Caenegem, E; Wierckx, K | 1 |
| Aranda, G; Fernández-Rebollo, E; Halperin, I; Hanzu, FA; Kalko, SG; Mora, M; Pradas-Juni, M | 1 |
| Conemans, EB; den Heijer, M; Nota, NM; Simsek, S; T'Sjoen, G; van Velzen, DM | 1 |
1 review(s) available for testosterone undecanoate and cyproterone acetate
| Article | Year |
|---|---|
Perspectives of contraceptive choices for men.
Topics: Carica; Clinical Trials as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Male; Cyproterone Acetate; Dimethyl Sulfoxide; Hormones; Humans; Male; Maleates; Norgestrel; Polyesters; Polystyrenes; Styrenes; Testosterone; Vasectomy | 2005 |
3 trial(s) available for testosterone undecanoate and cyproterone acetate
| Article | Year |
|---|---|
An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men.
Topics: Adult; Contraceptive Agents, Male; Cyproterone Acetate; Follicle Stimulating Hormone; Hematocrit; Hemoglobins; Humans; Luteinizing Hormone; Male; Sperm Count; Spermatogenesis; Testis; Testosterone; Testosterone Congeners | 1997 |
Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men.
Topics: Adult; Contraceptive Agents, Male; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Synergism; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Reference Values; Single-Blind Method; Sperm Count; Spermatogenesis; Testosterone; Time Factors | 2003 |
Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
Topics: Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Estradiol; Estrogens; Female; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Insulin; Lipid Metabolism; Male; Prospective Studies; Testosterone; Transsexualism; Waist-Hip Ratio; Young Adult | 2014 |
3 other study(ies) available for testosterone undecanoate and cyproterone acetate
| Article | Year |
|---|---|
Mortality and morbidity in transsexual patients with cross-gender hormone treatment.
Topics: Adolescent; Adult; Aged; Cyproterone; Cyproterone Acetate; Estrogens; Female; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Retrospective Studies; Sex Factors; Testosterone; Transsexualism | 1989 |
Effects of sex steroids on the pattern of methylation and expression of the promoter region of estrogen and androgen receptors in people with gender dysphoria under cross-sex hormone treatment.
Topics: Adolescent; Adult; Anthropometry; Cyproterone Acetate; DNA Methylation; Drug Administration Schedule; Epigenesis, Genetic; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Follicle Stimulating Hormone; Gender Dysphoria; Humans; Luteinizing Hormone; Male; Prolactin; Promoter Regions, Genetic; Prospective Studies; Receptors, Androgen; RNA, Messenger; Sex Hormone-Binding Globulin; Signal Transduction; Testosterone | 2017 |
Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care.
Topics: Adult; Androgen Antagonists; Androgens; Body Composition; Body Fat Distribution; Cyproterone Acetate; Dose-Response Relationship, Drug; Electric Impedance; Estradiol; Estrogens; Female; Humans; Luteinizing Hormone; Male; Precision Medicine; Sex Reassignment Procedures; Testosterone; Time Factors; Transgender Persons; Treatment Outcome; Young Adult | 2020 |